Effect of Pseudomonas aeruginosa exotoxin A on endotoxin-induced tumour necrosis factor production in murine lung

Journal of Medical Microbiology

Volumn 48, Issue 5, 1999, Pages 471-477

  Hirakata, Yoichi ^c   Kirikae, Teruo ^b   Kirikae, Fumiko ^b   Yamaguchi, Toshiyuki ^c   Izumikawa, Kohichi ^c   Takemura, Hiromu ^c   Maesaki, Shigefumi ^a   Tomono, Kazunori ^a   Yamada, Yasuaki ^c   Kamihira, Shimeru ^c   Nakano, Masayasu ^b   Kitamura, Satoshi ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PROTEINASE; CD14 ANTIGEN; CD18 ANTIGEN; ELASTASE; ENDOTOXIN; GLYCOPROTEIN P 15095; LIPOPOLYSACCHARIDE; MESSENGER RNA; PSEUDOMONAS EXOTOXIN; RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE RELEASE; FLOW CYTOMETRY; INFLAMMATION; INOCULATION; LD 50; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM;

EID: 0012721396     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-5-471     Document Type: Article

References (36)

1. 1. Neu HC. The role of Pseudomonas aeruginosa in infections. J Antimicrob Chemother 1983; 11 Suppl B: 1-13.
2. 2. Wood RE, Boat TF, Doershuk CF. Cystic fibrosis. Am Rev Respir Dis 1976; 113: 833-878.
3. 3. Mahenthiralingam E, Speert DP. Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum. Infect Immun 1995; 63: 4519-4523.
4. 4. Homma H, Yamanaka A, Tanimoto S et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 1983; 83: 63-69.
5. 5. Fujii T, Kadota J, Kawakami K et al. Long term effect of erythromycin therapy in patients with Pseudomonas aeruginosa infection. Thorax 1995; 50: 1246-1252.
6. 6. Kronborg G, Hansen MB, Svenson M, Fomsgaard A, Hoiby N, Bendtzen K. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr Pulmonal 1993; 15: 292-297.
7. 7. Bonfield TL, Panuska JR, Konstan MW et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-2118.
8. 8. Salva PS, Doyle NA, Graham L, Eigen H, Docrschuk CM. TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients. Pediatr Pulmonal 1996; 21: 11-19.
9. 9. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 1996; 63: 42-48.
10. 10. Liu PV. Extracellular toxins of Pseudomonas aeruginosa. J Infect Dis 1974; 130 Suppl: S94-S99.
11. 11. Nicas TI, Iglewski BH. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can J Microbiol 1985; 31: 387-392.
12. 12. Hirakata Y, Furuya N, Tateda K, Kaku M, Yamaguchi K. In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice. Infect Immun 1993; 61: 2468-2473.
13. 13. Jaffar-Bandjee MC, Lazdunski A. Bally M, Carrère J, Chazalette JP, Galabert C. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa J Clin Microbiol 1995; 33: 924-929.
14. 14. Suter S. The role of bacterial proteases in the apathogenesis of cystic fibrosis. Am J Respir Crit Care Med 1994; 150: S118-122.
15. 15. Brauner A, Cryz SJ, Granstrom M et al. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia. Eur J Clin Microbiiol Infect Dis 1993; 12: 430-436.
16. 16. Doring G, Obernesser H-J, Botzenhart K, Flehmig B, Høily N, Hofmann A. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J Infect Dis 1983; 147: 744-750.
17. 17 Woods DE, Cryz SJ, Friedman RL, Iglewski BH. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun 1982; 36: 1223-1228.
18. 18. Karber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmocol 1931; 162: 480.
19. 19. Irifune K, Shimoguchi K, Tateda K, Yamaguchi K, Hara K. A simple method of intratracheal inoculation into mice. J Clin Exp Med 1990; 152: 71.
20. 20. Kirikae F, Kirikae T, Qureshi N, Takayama K, Morrison DC, Nakano M. CD14 is not involved in Rhodobacter sphaeroides dishosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun 1995; 63: 486-497.
21. 21. Ito T, Kito K, Adati N, Mitsui Y, Hagiwara H, Sasaki Y. Fluorescent differential display: arbitrarily primed RT-PCR fingerprinting on an automated DNA sequencer. FEBS Lett 1994; 351: 231-236.
22. 22. Kawasaki ES, Clark SS, Coyne MY et al. Diagnosis of chronic mycloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85: 5698-5702.
23. 23. Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 6060-6064.
24. 24. Fujihara M, Ito N, Pace JL, Watanabe Y, Russell SW, Suzuki T. Role of endogenous interferon-β in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. J Biol Chem 1994; 269: 12773-12778.
25. 25. Golenbock DT, Liu Y, Millham FH, Freeman MW, Zoeller RA. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J Biol Chem 1993; 268: 22055-22059.
26. 26. Ingalls RR, Golenbock DT. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 1995; 181: 1473-1479.
27. 27. Kadota J, Matsubara Y, Ishimatsu Y et al. Significance of IL-1 beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin Exp Immunol 1996; 103: 461-466.
28. 28. Hirakata Y, Kaku M, Mizukane R et al. Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992; 36: 1922-1927.
29. 29. Yanagihara K, Tomono K, Sawai T et al. Effect of clarithromycin on lymphocytes in chronic respiratoiy Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 1997; 155: 337-342.
30. 30. Mizukane R, Hirakata Y, Kaku M et al. Comparative in vitro exoenzyme-suppressing activities of azythromycin and other macrolide antibiotics against Pseudomonas aeruginosa, Antimicrob Agents Chemother 1994; 38: 528-533.
31. 31. Nakano Y, Onozuka K, Terada Y, Shinomiya H, Nakano M. Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis. J Immunol 1990; 144: 1935-1941.
32. 32. Iglewski BH, Sadoff JC. Toxin inhibitors of protein synthesis: production, purification, and assay of Pseudomonas aeruginosa toxin A. Methods Enzymol 1979; 60: 780-793.
33. 33. Holt PS, Misfeldt ML. Alteration of murine immune response by Pseudomonsa aeruginosa exotoxin A. Infect Immun 1984; 45: 227-233.
34. 34. Misfeldt ML, Legaard PK, Howell SE, Fornella MH, LeGrand RD. Induction of interleukin-1 from murine peritoneal macrophages by Pseudomonas aeruginosa exotoxin A. Infect Immun 1990; 58: 978-982.
35. 35. Zehavi-Willner T. Induction of murine cytotoxic T lymphocytes by Pseudomonas aeruginosa exotoxin A. Infect Immun 1988; 56: 213-218.
36. 36. Staugas REM, Harvey DP, Ferrante A, Nandoskar M, Allison AC. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes. Infect Immun 1992, 60: 3162-3168.